More on Portola Pharma Q2 results

|About: Portola Pharmaceuticals (PTLA)|By:, SA News Editor

Portola Pharmaceuticals (PTLA -0.7%) Q2 results: Revenues: $2.4M (-7.7%); Operating Expenses: $33.9M (+38.4%); Operating Loss: ($31.5M) (-43.8%); Net Loss: ($31.4M) (-45.4%); Loss Per Share: ($0.76) (+48.3%); Quick Assets: $285.9M (-10.4%).

No guidance given.